Bigul

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Marksans Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
08-08-2013
Bigul

Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Mark Saldanha has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE
02-08-2013
Bigul

Financial Results & Limited Review for June 30, 2013

Marksans Pharma Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended June 30, 2013.
29-07-2013
Bigul

Updates

Marksans Pharma Ltd has informed BSE that:- The Company was registered with BIFR under SICA.In this connection, the Company has informed that, the Company has been de-registered from the purview of SICA and is no longer in BIFR as per the directions of the Honble BIFR in its hearing held on July 17, 2013. The summary record of proceedings of the hearing is awaited".
22-07-2013
Bigul

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Marksans Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
09-07-2013
Bigul

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Marksans Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
08-07-2013
Bigul

Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Mark Saldanha has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE
02-07-2013
Bigul

Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Mark Saldanha has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE
01-07-2013
Bigul

Financial Results & Auditors Report for March 31, 2013 (Audited)

Marksans Pharma Ltd has informed BSE about the Financial Results & a copy of the Auditors Report for the period ended March 31, 2013.
27-05-2013
Next Page
Close

Let's Open Free Demat Account